Potluri Sakshitha, Chittiprol Nethra, Varaganti Vamshi, Avr Vishnu, Vadakedath Sabitha, Arvapally Deepthi, Vemulapalli Chaitanya, Begum Gulam Saidunnisa, Madamsetti Naveen, Kandi Venkataramana
Medicine, Prathima Institute of Medical Sciences, Karimnagar, IND.
Health Sciences, Cypress Bay High School, Weston, USA.
Cureus. 2025 Aug 7;17(8):e89527. doi: 10.7759/cureus.89527. eCollection 2025 Aug.
Since its discovery, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has become the epicenter of public health concern. This was mainly attributed to the complexity of COVID-19 that resulted in variable disease progression with some developing asymptomatic infections, some suffering mild to moderate infections that resolved without the need for hospitalizations, and a few infected persons developing severe infections that required intensive care unit (ICU) admission and mechanical ventilation. The COVID-19 pandemic spread globally, affecting billions of people and killing millions. Most of the consequences were related to the novelty of the virus, poor understanding of its pathogenesis, and the lack of a specific antiviral drug and vaccine. The vaccines, although manufactured and made available to the public, were approved for emergency use before the completion of human clinical trials. Moreover, the continuous emergence of viruses following mutations resulted in the emergence of viral variants. This has led to doubts over the efficacy of vaccines. Vaccine inequity, represented by the disproportionate availability and distribution of vaccines among the rich and poor, concerns over long-term safety, and hesitancy, affected COVID-19 vaccination, thereby increasing the spread of SARS-CoV-2. Although the COVID-19 pandemic is no longer considered a public health emergency of international concern (PHEIC), the repercussions of the pandemic are still evident in the form of long COVID and post-COVID functional health status (PCFHS), wherein individuals who were previously infected continue to suffer organ dysfunction, primarily affecting the lungs and other organs of the body. During and after the pandemic, COVID-19 and probably vaccination were attributed to the death of many individuals, which were categorized as sudden death (SD) and sudden unnatural death (SUD). It is unclear if these deaths were a result of previous SARS-CoV-2 infection and prior COVID-19 vaccination or both. There are several instances of infected and recovered individuals who were healthy but suddenly developed complications and died. Through this explorative review, we aim to comprehend the role that SARS-CoV-2 infection and/or COVID-19 vaccination play in predisposing people to cardiovascular system (CVS) and central nervous system (CNS) disorders that can result in SD and SUD.
自新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2),即2019冠状病毒病(COVID-19)的病原体被发现以来,它已成为公共卫生关注的焦点。这主要归因于COVID-19的复杂性,其导致疾病进展各异,一些人发展为无症状感染,一些人遭受轻度至中度感染且无需住院即可康复,还有少数感染者发展为严重感染,需要入住重症监护病房(ICU)并接受机械通气。COVID-19大流行在全球蔓延,影响了数十亿人并导致数百万人死亡。大多数后果与病毒的新颖性、对其发病机制的了解不足以及缺乏特定的抗病毒药物和疫苗有关。这些疫苗虽然已生产并向公众提供,但在完成人体临床试验之前就被批准用于紧急用途。此外,病毒突变后不断出现新的变种。这引发了人们对疫苗效力的怀疑。疫苗不公平现象,表现为疫苗在贫富人群中的供应和分配不均衡、对长期安全性的担忧以及犹豫态度,影响了COVID-19疫苗接种,从而加剧了SARS-CoV-2的传播。尽管COVID-19大流行不再被视为国际关注的突发公共卫生事件(PHEIC),但大流行的影响仍以长期COVID和COVID后功能健康状况(PCFHS)的形式显现,即先前感染的个体继续遭受器官功能障碍,主要影响肺部和身体的其他器官。在大流行期间及之后,COVID-19以及可能的疫苗接种被认为是许多人死亡的原因,这些死亡被归类为猝死(SD)和非自然猝死(SUD)。目前尚不清楚这些死亡是先前SARS-CoV-2感染和先前COVID-19疫苗接种的结果,还是两者共同作用的结果。有多个感染后康复的个体,他们原本健康,但突然出现并发症并死亡的案例。通过这项探索性综述,我们旨在了解SARS-CoV-2感染和/或COVID-19疫苗接种在使人们易患可能导致SD和SUD的心血管系统(CVS)和中枢神经系统(CNS)疾病中所起的作用。